Clin2
NCT06742801Possibly a fitRecruiting

Onyx liquid embolic for active bleeding outside the brain and heart

Peripheral Arterial HemorrhageTraumaGI BleedUlcerHemorrhage

Part of Digestive system, Injuries & trauma clinical trials.

This trial tests a liquid material called Onyx that is injected into blood vessels to stop active bleeding in areas like the arms, legs, belly, or chest. It may help people with uncontrolled bleeding that needs to be blocked quickly.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
119 people
Ages
22 years and older
Study type
Interventional

Who can take part

  • You must be 22 years or older.
  • You have active bleeding in a blood vessel outside the brain and heart, confirmed by scans or cameras.
  • You or your legal representative can sign a consent form.
  • Your doctor believes you will live longer than 30 days.
  • The bleeding spot has not been treated with an embolization before.
  • You are not pregnant or breastfeeding.
  • You do not have an active infection or allergies to the Onyx liquid or imaging dyes.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07156409Not yet recruiting
Coil system for blocking abnormal blood vessels

This trial tests a new coil system designed to block blood flow in abnormal connections between arteries and veins in the arms, legs, or body. It may help patients who need this type of treatment without using other blocking materials.

NCT07753005Not yet recruiting
Stop bleeding with Histoacryl

This trial tests a glue-like substance called Histoacryl® to stop bleeding in the chest or belly. It is injected directly into the bleeding spot seen on scans or with a camera, and may help avoid surgery.

Nagoya, Aichi-ken
NCT07525518Enrolling by invitation
Okami Medical Device Patient Registry

This is a registry—a database that tracks patient outcomes—for people receiving Okami Medical devices. By joining, you help doctors understand how well these devices work and whether they're safe over time.

Aurora, Colorado
NCT07288489Recruiting· Phase 3
A study on VMX-C001 for urgent surgery while on blood thinners

This trial tests a drug called VMX-C001 to quickly reverse the effects of certain blood thinners (Factor Xa inhibitors) in people who need urgent surgery with a high risk of bleeding. It compares VMX-C001 to standard care to see which is more effective at helping blood clot normally.

Chandler, Arizona
NCT06479343Recruiting
Liquid embolic for brain vessel malformations

This trial tests a new liquid material (called a liquid embolic system) that is injected into the abnormal blood vessels in the brain to block them off. It is for people who have a cerebrovascular malformation and can be treated with a catheter from inside the blood vessel.

Guangzhou, Guangdong
NCT06577896Recruiting
Onyx stent safety and effectiveness in older adults

This study looks at how well a specific brand of heart stent (Onyx) works in people 75 and older who have narrowed heart arteries. If you've already received an Onyx stent, the study will check its safety and effectiveness over time.

Yangsan, Gyeongsangnam-do

Hear when a new Trauma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.